{"product_id":"new-targets-for-the-treatment-of-hypertension-and-associated-diseases-hardback-9780323910873","title":"New Targets for the Treatment of Hypertension and Associated Diseases (Hardback) 9780323910873","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNew Targets for the Treatment of Hypertension and Associated Diseases\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eEdited by some of the best scientists in this field, this series presents the latest updates on pharmacology\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eWilliam B. Campbell (Volume editor), John D. Imig (Volume editor)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323910873, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 7 June 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e420 pages\u003cbr\u003e22.9 x 15.1 x 2.7 cm, 0.45 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003ci\u003eNew Targets for the Treatment of Hypertension and Associated Diseases, Volume 94\u003c\/i\u003e in the \u003ci\u003eAdvances in Pharmacology\u003c\/i\u003e serial, highlights new advances in the field, with this new volume presenting interesting chapters on Cytochrome P450, 20-hydroxyeicosatetraenoic acid and GPR75 pathway in hypertension, Treatment of hypertension with soluble epoxide hydrolase inhibitors, Effects of allosteric modifiers of adenosine receptors in the heart, Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury, Drugs affecting the nitric oxide- cyclic GMP pathway in hypertension, Relaxin-2 and Serelaxin in renal and cardiac dysfunction in hypertension, and more.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. The CYP\/20-HETE\/GPR75 axis in hypertension \u003ci\u003eGhezal Froogh, Victor Garcia and Michal L. Schwartzman \u003c\/i\u003e2. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury \u003ci\u003eJohn D Imig \u003c\/i\u003e3. Pharmacological developments in antihypertensive treatment through nitric oxide-cGMP modulation \u003ci\u003eAnnika A. Jüttner, A.H. Jan Danser and Anton J.M. Roks \u003c\/i\u003e4. Sphingosine-1-phosphate and sphingosine-1-phosphate receptors in the cardiovascular system: Pharmacology and clinical implications \u003ci\u003eSimona Federica Spampinato, Maria Angela Sortino and Salvatore Salomone \u003c\/i\u003e5. Polymorphisms in common antihypertensive targets: Pharmacogenomic implications for the treatment of cardiovascular disease \u003ci\u003eDominique Brown, Heather Alcala, Peter Oelschlaeger and Bradley T. Andresen \u003c\/i\u003e6. Relaxin\/serelaxin for cardiac dysfunction and heart failure in hypertension \u003ci\u003ePrasad Chunduri, Shrey A. Patel and Scott P. Levick \u003c\/i\u003e7. Cardiovascular effects of GLP-1 receptor agonism \u003ci\u003eRaymond J. Winquist and Valentin K. Gribkoff \u003c\/i\u003e8. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease \u003ci\u003eHaiFeng Yang and Raouf A. Khalil \u003c\/i\u003e9. Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology \u003ci\u003eGiorgio Minotti, Pierantonio Menna, Massimiliano Camilli, Emanuela Salvatorelli and Roberto Levi\u003c\/i\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46651128578328,"sku":"9780323910873","price":152.87,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323910873_a7ad44c1-1cf7-4709-ac0c-117c9aaa7ebc.jpg?v=1694993375","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/new-targets-for-the-treatment-of-hypertension-and-associated-diseases-hardback-9780323910873","provider":"Freshly Printed Books","version":"1.0","type":"link"}